Beyond Air (XAIR) Capital Expenditures Growth (5y) (2022 - 2026)
Beyond Air (XAIR) Capital Expenditures Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.61 Bn | 175.32 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.22 Bn | 99.00 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.29 Bn | 66.84 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn |
| 6 | Dexcom | 28.31 Bn | 27.19 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.03 Bn | 25.75 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 24.04 Bn | 20.91 Bn | 2.07 Bn |
| 10 | Beyond Air | 2.23 Mn | -10.13 Mn | 94,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.10% |
| Dec 31, 2025 | -24.54% |
| Sep 30, 2025 | -12.78% |
| Jun 30, 2025 | -4.05% |
| Mar 31, 2025 | -204.39% |
| Dec 31, 2024 | 119.61% |
| Sep 30, 2024 | 140.43% |
| Jun 30, 2024 | 286.18% |
| Mar 31, 2024 | 240.55% |
| Dec 31, 2023 | 143.02% |
| Mar 31, 2023 | 358.31% |
| Dec 31, 2022 | 23.66% |
| Sep 30, 2022 | 63.27% |
| Jun 30, 2022 | 41.18% |
| Mar 31, 2022 | 68.46% |